# Dunen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dunen

- Industry: Healthcare
- Headquarters: Hangzhou, China
- Website: www.dunen.net
- Total disclosed funding: $15M
- Latest round: Series A (Feb 28, 2024)
- Investors on record: 2

## About

Based in Hangzhou, China, and established in 2017, Dunen is a biotechnology company that focuses on the precision medicine field and used the technology of gene testing. The core technology team members graduated from Tsinghua University, Fudan University, Zhejiang University and other universities. It is the landing unit of Precision Medicine Research Center under Zhejiang Tsinghua Yangtze River Delta Research Institute. In 2021, the company has acquired 15 national invention patents, 3 soft writings and national high-tech enterprise qualification application. In February 2024, Dunen closed series A+ funding.

Dunen is equipped with multiple testing equipment, including fluorescence quantitative instruments PCR, sequencer, mass spectrometry equipment, and separation and analysis equipment. The company developed multiple gene testing products for precision medicine, including gene testing for cardiology drugs, gene testing for immunity inhibitor drugs, gene testing for mental disease drugs, gene testing for pain diseases, and gene testing for children's drugs. Moreover, the company provides monitoring products for immunity inhibitor drugs, antidepressant drugs, antitumor drugs, antifungal drugs, and trace elements. Dunen also provides integrated service platforms such as new drug R&D CRO services and clinical precision drug platforms.

Dunen will focus on the research and development of products and reagents related to precision medication, the strengthening of research service capacity and the market expansion of the co-laboratory.

## Funding rounds

- Series A, Feb 28, 2024 — Jingyao Fund
- Series A, Apr 22, 2022, $15M — China International Capital Corporation

## Investors

- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series A
- Jingyao Fund (https://capitalatlas.ai/funds/jingyao-fund) — Series A